BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22508808)

  • 1. High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age.
    Brugières L; Remenieras A; Pierron G; Varlet P; Forget S; Byrde V; Bombled J; Puget S; Caron O; Dufour C; Delattre O; Bressac-de Paillerets B; Grill J
    J Clin Oncol; 2012 Jun; 30(17):2087-93. PubMed ID: 22508808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.
    Brugières L; Pierron G; Chompret A; Paillerets BB; Di Rocco F; Varlet P; Pierre-Kahn A; Caron O; Grill J; Delattre O
    J Med Genet; 2010 Feb; 47(2):142-4. PubMed ID: 19833601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
    Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
    Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in SUFU predispose to medulloblastoma.
    Taylor MD; Liu L; Raffel C; Hui CC; Mainprize TG; Zhang X; Agatep R; Chiappa S; Gao L; Lowrance A; Hao A; Goldstein AM; Stavrou T; Scherer SW; Dura WT; Wainwright B; Squire JA; Rutka JT; Hogg D
    Nat Genet; 2002 Jul; 31(3):306-10. PubMed ID: 12068298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
    Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N
    Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
    Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
    Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
    Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
    Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
    J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
    Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
    Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review.
    Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S
    Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
    Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
    Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
    Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
    Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.
    Taylor MD; Zhang X; Liu L; Hui CC; Mainprize TG; Scherer SW; Wainwright B; Hogg D; Rutka JT
    Oncogene; 2004 Jun; 23(26):4577-83. PubMed ID: 15077159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
    Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
    Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the Nijmegen breakage syndrome gene in medulloblastomas.
    Huang J; Grotzer MA; Watanabe T; Hewer E; Pietsch T; Rutkowski S; Ohgaki H
    Clin Cancer Res; 2008 Jul; 14(13):4053-8. PubMed ID: 18593981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
    Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
    Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis.
    Beauchamp RL; Banwell A; McNamara P; Jacobsen M; Higgins E; Northrup H; Short P; Sims K; Ozelius L; Ramesh V
    Hum Mutat; 1998; 12(6):408-16. PubMed ID: 9829910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AXIN1 mutations but not deletions in cerebellar medulloblastomas.
    Baeza N; Masuoka J; Kleihues P; Ohgaki H
    Oncogene; 2003 Jan; 22(4):632-6. PubMed ID: 12555076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital medulloblastoma in two brothers with SUFU-mutated Gorlin-Goltz syndrome: Case reports and literature review.
    Chen Y; Zhang H; Zhao Y; Ma J
    Front Oncol; 2022; 12():988798. PubMed ID: 36313636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.